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Yue Qi, MD, Jonathan R. Lindner, MD
Portland, Oregon
Objectives Our aim was to develop an echocardiographic molecular imaging approach for detecting recent myocardial isch-
emia by using recombinant P-selectin glycoprotein ligand (PSGL)-1 as a targeting ligand, which is a feasible ap-
proach for human use.
Background Ischemic memory imaging using human PSGL-1 as a targeting moiety may extend the time window for postisch-
emic detection by targeting the early (P-selectin) and late (E-selectin) endothelial ischemic response.
Methods Lipid microbubbles bearing recombinant human PSGL-1 (MBYSPSL) or P-selectin antibody (MBAb) were prepared.
Targeted attachment was evaluated by using flow chamber and intravital microscopy. In vivo ultrasound molecu-
lar imaging was first performed in the hindlimb in wild-type and P-selectin–deficient (P/) mice 45 to 360 min
after brief ischemia-reperfusion injury. Myocardial contrast echocardiography molecular imaging was performed
1.5, 3, 6, and 18 h after brief left anterior descending coronary artery ischemia-reperfusion.
Results Microbubble attachment to P-selectin–immunoglobulin G fusion protein in flow chamber experiments (shear
stress 0.5 to 8.0 dyne/cm2) and to activated venular endothelium on intravital microscopy were similar for MBAb
and MBYSPSL. Intense enhancement was seen for MBAb and MBYSPSL in postischemic muscle and was more sta-
ble over time for MBYSPSL. On myocardial contrast echocardiography, both MBYSPSL and MBAb produced similar
signal enhancement at 90 min and 3 h after ischemia, which spatially correlated with the postischemic risk
area. Signal significantly decreased but was still present at 6 to 18 h.
Conclusions Echocardiographic molecular imaging with a human multi-selectin–targeted contrast agent bearing recombinant
human PSGL-1 can detect myocardial ischemia hours after resolution. This approach may potentially be used for
rapid bedside evaluation of patients with recent chest pain. (J Am Coll Cardiol 2012;60:1690–7) © 2012 by
the American College of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.07.027There are well-recognized limitations in the algorithms
currently used to diagnose acute coronary syndromes (ACS)
in patients who present with symptoms but whose initial
electrocardiogram does not show ST-segment elevation
(1–3). Various noninvasive imaging techniques have been
proposed for improving diagnostic accuracy in patients with
possible ACS. Molecular imaging has been used to detect
biochemical alterations that occur not only during ischemia
but also persist after ischemia resolves. This approach, often
referred to as ischemic memory imaging, may be particularly
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accepted July 10, 2012.useful for detecting ischemia when the amount of necrosis is
small or in patients who present after symptoms resolve or
have pre-existing electrocardiogram or wall motion abnor-
malities. Ideally, molecular imaging should be able to detect
and assess the spatial extent of ischemia hours after its
resolution and provide information rapidly to the clinician.
Because of its portability and speed, myocardial contrast
echocardiography (MCE) molecular imaging has been pro-
posed as a point-of-care technique for rapidly detecting
recent myocardial ischemia. MCE detection of myocardial
ischemia after transient reduction in coronary flow has been
achieved by targeting microbubble contrast agents to endo-
thelial P-selectin (4,5). Selectins are a family of endothelial
adhesion molecules that bind carbohydrate-bearing counterli-
gands on leukocytes and are expressed in response to ischemia
and other inflammatory stimuli (6,7). P-selectin is stored
preformed in endothelial cells and expressed within minutes of
ischemia or injury (8,9). However, the duration over which
P-selectin imaging would be effective for detecting recent
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October 23, 2012:1690–7 Ischemic Memory Imaging With MCEischemia is uncertain because its surface expression tends to
diminish over time after an ischemic insult. In the present
study, we hypothesized that the time window for ischemic
memory imaging could be extended by targeting not only
P-selectin but also E-selectin, which exhibits delayed but
more persistent expression for up to 24 h after endothelial
activation (10 –12). Accordingly, we developed a novel ultra-
sound contrast agent bearing a recombinant form of human
P-selectin glyocoprotein (PSGL)-1, an endogenous counterligand
for both P- and E-selectin. The use of recombinant human
PSGL-1 as a targeting moiety also represents an impor-
tant step toward the development of a human-ready
agent for myocardial ischemic memory imaging with
echocardiography.
Methods
Targeted microbubble preparation. Biotinylated lipid-
shelled decafluorobutane microbubbles were prepared by
sonication of an aqueous suspension of distearoylphosphati-
dylcholine, polyoxyethylene-40-stearate, and distearoyl-
phosphatidylethanolamine-polyethylene glycol (PEG)(2000)-
biotin in a 50:10:1 molar ratio. Conjugation of biotinylated
ligand to the microbubble surface was performed by using a
streptavidin bridge as previously described (13) to create the
following agents: MBYSPSL: bearing an immunoglobulin G
IgG) fusion protein with a dimeric recombinant form of
he glycoprotein PSGL-1 (YSPSL, Y’s Therapeutics Co.,
td., Tokyo, Japan); MBAb: bearing rat anti-mouse
-selectin monoclonal antibody (mAb) (RB40.34, BD
harmingen, San Jose, California); or MBCtr: bearing iso-
type control mAb (R3-34, BD Pharmingen). For flow
chamber studies and intravital microscopy, MBAb and
MBYSPSL were fluorescently labeled by the addition of
dioctadecyltetramethylindocarbocyanine or dioctadecylox-
acarbocyanine perchlorate, respectively, to the microbubble
shell. Perfusion imaging was performed with microbubbles
lacking distearoyl-phosphatidylethanolamine-PEG(2000)-
biotin. Microbubbles were analyzed for concentration and
size distribution (Multisizer III, Beckman-Coulter, Brea,
California). Intravascular half-life for each agent was deter-
mined by left ventricular cavity intensity on MCE after
intravenous injection of 5  106 microbubbles.
Flow chamber attachment. Cell culture dishes were coated
with an IgG fusion protein bearing murine P-selectin (BD
Pharmingen Inc.) at a site density of approximately 100
m–1(14). The dishes were blocked with 3% bovine serum
albumin and mounted on a parallel plate flow chamber
(Glycotech Inc., Gaithersburg, Maryland) that was placed
in an inverted position on a microscope (Axioskop2-FS,
Carl Zeiss Inc., Thornwood, New York) for video record-
ing. Suspensions of fluorescently labeled MBYSPSL and
BAb (3  10
6 ml–1) were drawn through the flow
chamber at flow rates resulting in calculated shear stresses of
0.5, 1.0, 2.0, or 8.0 dynes/cm2. The number of micro-
bubbles attached to the plate was determined for 20 optical afields after 3 min of continuous
flow. Experiments were per-
formed in duplicate for each
condition.
Animal preparation. Studies
were approved by the Animal
Care and Use Committee at Or-
egon Health & Science Univer-
sity. Male wild-type C57Bl/6
mice and P-selectin– deficient
(P/) mice (Jackson Labs) 10 to
15 weeks of age were studied. For
intravital microscopy, mice were
anesthetized with an intraperito-
neal injection (12.5 l/g) of a so-
lution containing ketamine hydro-
chloride (10 mg/ml), xylazine (1
mg/ml), and atropine (0.02 mg/
ml). For molecular imaging, mice
were anesthetized with inhaled iso-
flurane (0.75% to 1.5% for mainte-
nance). A jugular vein was cannu-
lated for injection of microbubbles.
Intravital microscopy. A cremaster muscle in wild-type
mice (n  3) was prepared as previously described (15).
Video recordings were made with a microscope and re-
corded with a charge-coupled device camera (C2400,
Hamamatsu Photonics). Muscle preparations were studied
20 to 30 min after exteriorization, and P-selectin expression
from surgical trauma was confirmed by the presence of
leukocyte rolling in postcapillary venules (9). Fluorescently
labeled MBYSPSL and MBAb (1  10
7) were simultaneously
njected intravenously. Microbubble attachment in 10 to 15
andomly selected optical fields was quantified 2 to 4 min
fter injection using fluorescent epi-illumination.
ontrast-enhanced ultrasound. Imaging was performed
ith a linear array transducer (15L8) interfaced with a
equoia ultrasound system (Siemens Medical Systems,
ountain View, California). A multipulse algorithm using
hase and amplitude modulation was used to detect the
onlinear fundamental component of the microbubble sig-
al. Imaging was performed at a centerline frequency of 7
Hz.
indlimb molecular imaging protocol. Contrast-enhanced
ltrasound molecular imaging of the proximal hindlimb
dductor muscles was performed after unilateral ischemia-
eperfusion injury produced by tourniquet occlusion for 10
in. Ischemia was confirmed by a 95% reduction in flow
ccording to contrast-enhanced ultrasound perfusion imag-
ng. Molecular imaging was performed in the postischemic
imb at 45, 90, 180, and 360 min after ischemia in 20
ild-type and 9 P/ mice and bilaterally in 3 control
wild-type mice not undergoing ischemia-reperfusion. In 4
additional P/ mice, imaging was performed at 360 min
fter blocking E-selectin by intravenous injection of rat
Abbreviations
and Acronyms
ACS  acute coronary
syndrome
IgG  immunoglobulin G
LAD  left anterior
descending coronary artery
mAb  monoclonal
antibody
MBAb  microbubbles
bearing P-selectin antibody
MBYSPSL  microbubbles
bearing recombinant human
P-selectin glycoprotein
ligand-1
MCE  myocardial contrast
echocardiography
MI  mechanical index
PEG  polyethylene glycol
PSGL  P-selectin
glycoprotein ligandnti-mouse E-selectin mAb (UZ4, Millipore Billerica,
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Ischemic Memory Imaging With MCE October 23, 2012:1690–7Massachusetts). Imaging was performed by using low power
imaging (mechanical index [MI] 0.18) 8 min after intrave-
nous injection of MBYSPSL and MBAb (1  10
7) performed
n random order. Comparison of control microbubble
MBCtr) to both targeted agents was performed in an
dditional 12 wild-type and 6 P/ mice at the 45 min
ostischemic time interval only. For all image sets, signal for
etained microbubbles alone was derived by digitally sub-
racting the signal from freely circulating microbubbles as
reviously described (13).
yocardial molecular imaging protocol. Mice were
laced on positive-pressure ventilation. Ligature occlusion
f the LAD through a left lateral thoracotomy was per-
ormed to produce brief myocardial ischemia confirmed by
T-segment elevation on electrocardiogram monitoring.
he ligature was released after 10 min but was left in place,
nd the chest wall was closed. Mice were extubated, and
all motion was assessed within 10 min of reperfusion and
gain at 3 h using high-frequency (30 MHz) echocardiog-
aphy (Vevo 770, Visualsonics, Toronto, Ontario, Canada)
n the midventricular short-axis plane. MCE molecular
maging was performed in the same imaging plane at 1.5
nd 3 h in 8 wild-type mice or at 6 and 18 h in 6 wild-type
ice. In 2 P/ mice, imaging was performed at the
ntermediate postischemic intervals (3 and 6 h). Imaging
as performed 3 and 6 h after sham surgery with ligature
lacement but no occlusion in 3 wild-type mice. For
olecular imaging, first low MI (0.16) then high MI (1.4)
maging was performed 8 min after injection of 5  106
MBAb or MBYSPSL in random order. Several end-systolic
mages were acquired and averaged, and signal for retained
icrobubbles alone was derived by digitally subtracting the
ignal from freely circulating microbubbles at the appropri-
te MI (Online Fig. 1) (13). After completion of molecular
maging, the ischemic risk area was measured by reopening
he chest, retying the LAD ligature, and injecting 1  1011
Figure 1 In Vitro Attachment of Targeted Microbubbles
Mean  SEM number of targeted microbubbles attached to P-selectin–immunoglo
shear stresses. Each optical field represents 0.09 mm2. Microbubble adhesion in
antibody; MB  microbubbles bearing recombinant human P-selectin glycoproYSPSLfluorescently labeled 500 nm polystyrene nanospheres
(Duke Scientific Corp., Palo Alto, California) intrave-
nously. After 2 min of circulation time, the heart was
removed, and a 1-mm short-axis section corresponding to
the echocardiographic imaging plane was examined by using
fluorescent microscopy. The fluorescent-free risk area was
used to guide region-of-interest selection for MCE molec-
ular imaging and quantitative wall motion analysis. The risk
area averaged from the basal and apical aspects of the histo-
logical slice and the area of enhancement on molecular imaging
were measured independently by readers blinded to animal
identity. In selected animals, the left ventricle was divided in
1-mm short-axis slices and stained with 2,3,5-
triphenyltetrazolium chloride to exclude infarction.
Statistical analysis. Comparisons between microbubble
agents for the flow chamber studies and intravital micros-
copy were made with a Mann-Whitney rank-sum test. For
both, paired analysis was performed on a per-optical field
basis. For multiple comparisons of the in vivo imaging data,
a Kruskal-Wallis test with Dunn’s post-hoc test was used.
Differences were considered significant at p  0.05.
Results
Microbubble attachment in physiological shear. Micro-
bubble size distribution was similar between targeted mi-
crobubble agents, and intravascular half-life was slightly
shorter for MBAb compared with MBYSPSL (Online Figs. 2
and 3). Flow chamber experiments demonstrated that firm
adhesion of microbubbles to P-selectin–IgG fusion protein
was similar for MBYSPSL and MBAb across a range of shear
tresses (Fig. 1).
Surgical exteriorization of the cremaster muscle for intra-
ital microscopy produced leukocyte rolling (10 to 110
m/s) in postcapillary venules consistent with endothelial
selectin expression (9). Endothelial attachment of micro-
fusion protein (site density of 100 m–1) in a flow chamber under various
w chamber is illustrated to the right. MBAb  microbubbles bearing P-selectin
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October 23, 2012:1690–7 Ischemic Memory Imaging With MCEbubbles after intravenous injection was similar for MBYSPSL
and MBAb (Fig. 2, Online Videos 1, 2, and 3) and occurred
lmost exclusively in post-capillary venules. Microbubble
olling along the venular endothelial surface was occasion-
lly observed only with MBYSPSL, which constituted 10%
f all endothelial-microbubble interactions. Leukocyte roll-
ng was observed in all venular segments in which micro-
ubble attachment was seen.
olecular imaging in postischemic skeletal muscle. As
n initial step to evaluate temporal patterns of microbubble
etention, hindlimb ischemia was used because of the
tability of the preparation. Strong signal enhancement 45
in after ischemia from both targeted agents was detected
n wild-type mice, which was not seen in postischemic P/
mice, in nonischemic controls, or from control micro-
bubbles in any treatment group (Fig. 3). Temporal charac-
terization was therefore performed only for targeted agents
(Fig. 4). Signal from MBAb in the postischemic limb of
wild-type mice peaked at 90 min after reflow and then
diminished over time so that signal intensity had decreased
by approximately one-half at 6 h (Fig. 4A). Lower signal
was found at all time points for MBYSPSL, yet the signal
roduced by this agent remained more stable over time. In
/ mice, there was no signal enhancement in the isch-
emic limb for MBAb at all time points, whereas MBYSPSL
Figure 2 Microbubble Attachment to Mouse Cremasteric Venu
(A) Mean  SEM number of retained microbubbles per optical field. Intravital m
rolling leukocytes (arrowheads) on bright field microscopy, (C) venular adhesio
dioctadecyloxacarbocyanine-labeled MBYSPSL, and (E) merged images. Also see Onlineproduced late signal enhancement that, at 6 h, was similar inintensity to that in wild-type mice (Fig. 4B) and was
abolished by blocking E-selectin.
Post-ischemic imaging of the myocardium. For mice
undergoing transient LAD ischemia, the mean risk area was
46% of the myocardial area (range 24% to 61%). Shortly after
reperfusion, a reduction in radial wall thickening fraction was
seen in the center of the risk area compared with the remote
region (0.12 0.10 vs 0.33 0.08, p 0.01), which resolved
when remeasured at 3 h (0.25  0.08 vs 0.28  0.07),
consistent with brief postischemic stunning. Postmortem
2,3,5-triphenyltetrazolium chloride staining did not de-
tect myocardial infarction in any slice (Online Fig. 4). At
1.5 and 3 h after ischemic injury, MBYSPSL and MBAb
produced strong and equivalent signal enhancement in the
postischemic territory for both low- and high-power imag-
ing (Figs. 5A and 5C; log-linear transformed data in Online
ig. 5). At 6 and 18 h, targeted signal was much lower and
ot significantly different from the remote nonischemic
egions. Very low signal enhancement was seen in control
xperiments (Figs. 5B and 5D), which included nonsurgical
controls, sham-operated animals, and P/ mice undergo-
ing ischemic injury. Data from sham-operated experiments
indicated that signal from targeted agents in the remote
nonischemic zone was likely an artifact of injury from the
open-chest preparation. The spatial territory of enhance-
copy images of the cremaster muscle illustrate (B) converging venules with
ioctadecyltetramethylindocarbocyanine-labeled MBAb, (D) venular adhesion of
s Online Videos 1, 2, and 3. Abbreviations as in Figure 1.les
icros
n of d
Videoment from MBYSPSL and MBAb correlated modestly with
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Ischemic Memory Imaging With MCE October 23, 2012:1690–7the spatial extent of the risk area (Fig. 6). The correlation
was better at 1.5 than 3 h due primarily to a time-dependent
reduction in the area of ultrasound enhancement.
Discussion
In this study, we developed and evaluated a novel approach
to echocardiographic ischemic memory imaging by using a
multi-selectin–targeted microbubble contrast agent bearing
human recombinant dimeric PSGL-1. This agent not only
Figure 3 Molecular Imaging 45 min After Ischemia-Reperfusion
Mean  SEM video intensity for control microbubbles (MBCtr) and selectin-targeted
and P-selectin–deficient (P/) mice, and in control mice not undergoing ischemia
sound molecular imaging with MBAb after ischemia in a wild-type and P
/ mice. C
Abbreviations as in Figure 1.
Figure 4 Molecular Imaging Signal in the Post-Ischemic Hindlim
Mean  SEM video intensity for selectin-targeted microbubbles (MBAb and MBYSPS
and (B) P-selectin–deficient mice (P/). UZ4  anti–E-selectin monoclonal antibo
45 to 180 min; ‡p  0.05 versus corresponding untreated data at 360 min.represents a feasible approach for human imaging but also
has the potential to extend the time window for detecting
recent ischemia by targeting E-selectin. In murine models
of ischemia, this dual-selectin–targeted agent was able to
detect and spatially represent recent ischemia without in-
farction. It had a more stable quantitative signal over time than
mAb-based targeting in skeletal muscle but not the heart.
Interest in ischemic memory imaging is a consequence of
the diagnostic challenges in patients who present with acute
y of the Hindlimb
bubbles in the post-ischemic proximal hindlimb adductor muscles in wild-type
ples illustrate hindlimb two-dimensional anatomy and contrast-enhanced ultra-
cale at bottom. *p  0.05 versus targeted agents; †p  0.01 versus wild-type.
Various Reperfusion Intervals
he proximal hindlimb adductor muscles of the postischemic limb in (A) wild-type
her abbreviations as in Figure 1. *p  0.05 versus 90 min; †p  0.05 versusInjur
micro
. Exam
olor sb at
L) in t
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1695JACC Vol. 60, No. 17, 2012 Davidson et al.
October 23, 2012:1690–7 Ischemic Memory Imaging With MCEchest pain or other possible ischemic symptoms. In patients
who have ACS, the electrocardiogram and serological
markers are often nondiagnostic, leading to delayed or even
missed diagnosis. Furthermore, there are disease states other
than ischemia that can result in false-positive or uninter-
pretable results for these tests. Methods to noninvasively
image myocardial ischemia are being developed in response
to these recognized limitations. Moreover, in those patients
who have recognized ACS, defining the spatial extent of
ischemia can be potentially useful for stratifying treatment
according to the amount of myocardium at risk.
Interest in an echocardiographic approach is based on
practical issues such as cost, availability, and speed. Echo-
cardiographic imaging of wall motion and perfusion in the
emergency department can provide rapid diagnostic and
prognostic information in patients who have chest pain (16).
This information may be of limited value when performed
late after resolution of symptoms or in those with pre-existing
abnormalities in perfusion and/or function. Molecular imaging
Figure 5 Signal Enhancement From Myocardial Ischemic Memo
Data represent mean  SEM video intensity. (A) Low-power imaging data in wild-t
artery (LAD). (B) Low-power control experiments, which include nonsurgical control
undergoing LAD ischemia-reperfusion injury. (C) High-power imaging data in wild-ty
experiments. *p  0.05 versus remote territory; †p  0.05 versus ischemic territof ischemia for diagnosis of ACS is contingent on the ability todetect events that occur rapidly at the onset of ischemia and
persist for hours after resolution. For imaging recent ischemia,
microbubbles have been targeted to P-selectin via the conju-
gation of either mAb or selectin-specific carbohydrates to their
surface (4,5,13). Although initial reports of using P-selectin to
detect injury were made using renal ischemia, recent studies
have confirmed that it is also possible to detect myocardial
ischemia without infarction.
In this study, the use of human recombinant dimeric
PSGL-1 as a targeting moiety represents an important step
toward a human-ready agent. This molecule has the neces-
sary carbohydrate modifications required for selectin bind-
ing and has been investigated as an immunomodulatory
agent in human clinical trials (17). The ability to target
multiple selectins is potentially an advantage because
postischemic selectin expression has an early phase in-
volving preformed P-selectin stored within the Weibal-
Palade bodies of endothelial cells and a later phase
expression that includes E-selectin. Thus, we hypothe-
aging With Selectin-Targeted Microbubbles
ce undergoing ischemia-reperfusion injury of the left anterior descending coronary
ls, sham-operated animals at 3 and 6 h, and P-selectin–deficient (P/) mice
e undergoing ischemia-reperfusion injury of the LAD. (D) High-power control
P/ mice. Abbreviations as in Figure 1.ry Im
ype mi
anima
pe mic
ory insized that the ability to target both selectins would extend
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Ischemic Memory Imaging With MCE October 23, 2012:1690–7the time window for which it is possible to detect recent
ischemia.
The in vitro and in vivo adhesion studies indicated a similar
degree of attachment at various shear rates for mAb- and
PSGL-1–targeting approaches. On intravital microscopy, sur-
gical preparation of the cremaster muscle typically produces
heterogeneity in the amount of venular leukocyte rolling.
Microbubble attachment occurred only in venular segments
with rolling leukocytes. Microbubble attachment to immobi-
lized platelets, which also express P-selectin particularly on
activation, was not observed, although we did not use a model
that produces much platelet adhesion. Rolling before adhesion
was not a frequent finding on intravital microscopy.
Mouse hindlimb imaging was used as a reproducible
model for characterizing the temporal course of micro-
bubble retention after ischemia. These experiments indi-
cated that MBYSPSL had a more stable degree of postisch-
mic enhancement than MBAb. This attribute, according to
/ mouse data, was attributable to the MBYSPSL binding
o delayed E-selectin expression.
For myocardial ischemic memory imaging, our data
uggest that selectin targeting provides robust information
n the presence of ischemia for several hours after resolu-
ion. The mAb and PSGL-1 approaches provided relatively
quivalent signal. Signal enhancement even at 6 h was
argely suppressed in P/ mice. These data suggest less of
Figure 6 Spatial Assessment of Recent Ischemia With Molecu
Relation between risk area determined by fluorescent nanospheres and region of
colors correspond to their respective data points; red dashed line  line of identi
tion illustrating the nanosphere-derived risk area in the anterior myocardium (dark
cardial contrast echocardiography molecular imaging with MBYSPSL obtained 90 mi
Cavity size differences are due to postmortem contracture. Abbreviations as in Figa contribution of E-selectin to MBYSPSL signal in themyocardium compared with skeletal muscle. However, be-
cause rolling or adhesion of leukocytes and, by inference,
microbubbles is dependent on the interacting types and
numbers of ligand-counterligand bonds, the P/ data do
not necessarily exclude the contribution of E-selectin to late
postischemic myocardial signal enhancement. Our data also
suggest that molecular imaging can provide a relatively
accurate representation of the spatial extent of recent isch-
emia only if performed relatively early (3 h) after injury,
although results in humans may certainly differ. The corre-
lations between risk area and enhancement area were only
modest. We believe this finding is primarily due to several
factors, the first being related to scale in which there is
difficulty coregistering MCE molecular imaging data, which
were averaged from a 1.0- to 1.2-mm beam elevation
(thickness) with a single slice obtained for nanosphere-
derived risk area, a factor underscored by the finding on
several histological slices that the nanosphere-derived risk
area varied by as much as 8% of total area depending on
whether the basal or apical aspect of the slice was examined.
The second factor is the likelihood for selectin expression in
ischemic regions extending beyond the area that lacked
nanospheres because risk area was defined as the territory
completely void of nanospheres.
The disparity in signal intensity and the degradation of
signal over time for MBAb versus MBYSPSL for the hindlimb
aging
ement during molecular imaging at either (A) 90 min or (B) 3 h. Regression line
0.05 only for 90-min correlations. (C) Example of a myocardial short-axis sec-
), two-dimensional high-frequency imaging as an anatomic reference, and myo-
3 h after left anterior descending coronary artery ischemia-reperfusion injury.lar Im
enhanc
ty; p 
region
n and
ure 1.and myocardial studies may be explained several ways.
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October 23, 2012:1690–7 Ischemic Memory Imaging With MCEAlthough the ischemic duration was very brief for both
models, the degree of ischemia was probably greater for the
myocardium due to higher oxygen debt. Second, there are
data to suggest that basal and inducible expression of
endothelial adhesion molecules in the microcirculation can
differ according to tissue type (10,18,19). The greater
severity of ischemia in the myocardium may have produced
a greater degree of E-selectin expression and a longer
duration of signal enhancement for MBYSPSL (20).
tudy limitations. There are several limitations of this
tudy that deserve attention. Endothelial surface expression
f selectins was not quantified because there is no available
ethod to do so. It is also possible that intravascular
ctivation and recruitment of leukocytes may have contrib-
ted to postischemic tissue signal by nonspecific
icrobubble-leukocyte attachment, although previous stud-
es indicate that the contribution of this is minimal (13). We
id not vary the duration of ischemic insult and instead used
nly a very mild degree of ischemia to test our agents. For
uture use in humans, ligand conjugation strategies other
han biotin-streptavidin are being used, and pharmacology
nd toxicology will need to be evaluated. We do not believe
his change in formulation reduces the impact of this study
ecause the use of a PEG spacer and stoichiometry of the
igand will probably not differ substantially for the human-
eady agent. Finally, we used recombinant human PSGL-1
n murine models of ischemia. The relative benefit of using
dual selectin-targeted imaging agent and the duration that
schemia can be detected may be different in humans.
onclusions
e found that a recombinant form of the endogenous ligand
or P- and E-selectin as a targeting ligand could be used to
etect recent myocardial ischemia for a several hours after its
esolution even when wall motion had normalized. This
maging strategy offers a potentially useful rapid bedside risk
tratification tool to not only detect recent myocardial ischemic
ut also to evaluate the spatial extent of myocardium at risk.
Reprint requests and correspondence: Dr. Jonathan R. Lindner,
Cardiovascular Division, UHN-62, Oregon Health & Science
University, 3181 SW Sam Jackson Park Road, Portland, Oregon
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